This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The settlement marks OCR's sixth enforcement action in its "Risk Analysis Initiative," the HHS said in an April 10 update specific to the Northeast Radiology breach of unsecured electronic protected health information (ePHI) that the company reported in March 2020. The company will also be monitored for compliance for two years.
Medicalimagesmanagement: how implementing proper processes and quality control can ensure maximum operational effectiveness and regulatory compliance Between February 2018 and March 2019, ~44.9 million diagnostic imaging tests were performed in England [i]. in managingimages, and several components have evolved.
The Value of Standardized Quality and Performance Metrics in Clinical Trials It’s not just tumor measurements that matter! Imaging biomarker metrics are not the only measurements that matter in oncology imaging trials. Biopharma organizations optimize clinical trials by operationalizing both quality and performance metrics.
While AI offers tremendous potential to improve data management and streamline patient care, the technology also introduces a variety of risks that must be carefully addressed at every stage of the adoption process from strategy and integration to change management and governance.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content